SCHEMBL208570

SCHEMBL208570

CC(C)(C)[Si](C)(C)OC1CCC(N2CCC(Cc3c(Cl)cc(-c4ccc(C(=O)N5CCSCC5)cc4)cc3Cl)C2=O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 1/20 0.35
GABRA5 P31644 4/20 0.34
HRH1 P35367 2/20 0.33
CCR3 P51677 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
JAK1 P23458 1/20 0.33
CNR2 P34972 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HRH3 Q9Y5N1 3/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PARP1 P09874 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209103 1.00 HPGD (0.35) HPGDALDH1A1HSD17B10GABRA5HRH1
SCHEMBL208571 1.00 HPGD (0.35) HPGDALDH1A1HSD17B10GABRA5HRH1
SCHEMBL209102 1.00 HPGD (0.35) HPGDALDH1A1HSD17B10GABRA5HRH1
SCHEMBL210980 0.92 HRH3 (0.40) HPGDALDH1A1HRH1NPSR1HRH3
SCHEMBL208200 0.92 HRH3 (0.40) HPGDALDH1A1HRH1NPSR1HRH3
SCHEMBL210979 0.92 HRH3 (0.40) HPGDALDH1A1HRH1NPSR1HRH3
SCHEMBL209532 0.91 HRH1 (0.33) ALDH1A1HRH1CCR3NPSR1HRH3
SCHEMBL209533 0.91 HRH1 (0.33) ALDH1A1HRH1CCR3NPSR1HRH3
SCHEMBL209757 0.91 PARP1 (0.41) HPGDHRH1CCR3RAB9ANPSR1
SCHEMBL211810 0.91 HRH1 (0.33) ALDH1A1HRH1CCR3NPSR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HPGD 120/4885ALDH1A1 88/4885HSD17B10 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.